Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.

Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section.

Eur J Neurol. 2006 Nov;13(11):1170-85. Review.

PMID:
17038031
2.

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.

Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section.

Eur J Neurol. 2006 Nov;13(11):1186-202. Review.

PMID:
17038032
3.

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH.

Eur J Neurol. 2013 Jan;20(1):5-15. doi: 10.1111/j.1468-1331.2012.03866.x. Review.

PMID:
23279439
4.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3:S2-41. doi: 10.1002/mds.23829. Review.

PMID:
22021173
5.

Treatment of Parkinson's disease.

Martin WR, Wieler M.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S27-33. Review.

PMID:
12691474
6.

Treatment interventions for Parkinson's disease: an evidence based assessment.

Rascol O, Goetz C, Koller W, Poewe W, Sampaio C.

Lancet. 2002 May 4;359(9317):1589-98. Review.

PMID:
12047983
7.

A review of Parkinson's disease.

Davie CA.

Br Med Bull. 2008;86:109-27. doi: 10.1093/bmb/ldn013. Epub 2008 Apr 8. Review.

PMID:
18398010
8.

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.

Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Högl B, Benes H, Jennum P, Partinen M, Fer D, Montagna P, Bassetti CL, Iranzo A, Sonka K, Williams AM; European Federation of Neurological Societies; European Neurological Society; European Sleep Research Society.

Eur J Neurol. 2012 Nov;19(11):1385-96. doi: 10.1111/j.1468-1331.2012.03853.x. Epub 2012 Sep 3.

PMID:
22937989
9.

Management of Parkinson's disease a review of current and new therapies.

Mendis T, Suchowersky O, Lang A, Gauthier S.

Can J Neurol Sci. 1999 May;26(2):89-103. Review.

PMID:
10352867
10.

Parkinson's disease. Update in diagnosis and symptom management.

Marjama-Lyons JM, Koller WC.

Geriatrics. 2001 Aug;56(8):24-5, 29-30, 33-5. Review.

PMID:
11505857
11.
12.

Non-motor symptoms may herald Parkinson's disease.

Khoo TK, Burn DJ.

Practitioner. 2009 Sep;253(1721):19-24, 2.

PMID:
19873855
13.

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

Goetz CG, Poewe W, Rascol O, Sampaio C.

Mov Disord. 2005 May;20(5):523-39. Review.

PMID:
15818599
14.

The management of patients with early Parkinson's disease.

Rascol O, Brefel-Courbon C, Payoux P, Ferreira J.

Adv Neurol. 2003;91:203-11. Review. No abstract available.

PMID:
12442679
15.

Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.

Leroi I, Collins D, Marsh L.

J Neurol Sci. 2006 Oct 25;248(1-2):104-14. Epub 2006 Jun 27. Review.

PMID:
16806271
16.

New small molecules for the treatment of Parkinson's disease.

Müller T.

Expert Opin Investig Drugs. 2010 Sep;19(9):1077-86. doi: 10.1517/13543784.2010.504711. Review.

PMID:
20645881
17.

Treatment of early Parkinson's disease. Part 2.

Simuni T, Lyons KE, Pahwa R, Hauser RA, Comella C, Elmer L, Weintraub D.

Eur Neurol. 2009;61(4):206-15. doi: 10.1159/000197104. Epub 2009 Jan 29. Review.

18.

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M.

Eur J Neurol. 2013 Jan;20(1):16-34. doi: 10.1111/ene.12022. Review. Erratum in: Eur J Neurol. 2013 Feb;20(2):406.

PMID:
23279440
19.

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.

Vu TC, Nutt JG, Holford NH.

Br J Clin Pharmacol. 2012 Aug;74(2):267-83. doi: 10.1111/j.1365-2125.2012.04192.x.

20.

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004554. Review.

PMID:
15495119

Supplemental Content

Support Center